MEND Climbs On Acquisition News
Tags: merger and acquisition
Micrus Endovasuclar Corp (NASDAQ: MEND) shares are up about 4.5% in early morning trade after reports of Johnson & Johnson (NYSE: JNJ) buying MEND hit the market. JNJ is paying $23.40 a share, or $480 million, for MEND.
The volume of MEND shares traded so far today has reached 2,444,126, as against its 3-month average volume of 155,778. MEND has gained 47.93% so far this year, and 8.40% over the past week.
At 11:09 am, MEND was trading at $23.16, up 4.37%.
Read more from Benzinga's Markets.
(c) 2012 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We're Loving
